GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (NYSE:WAT) » Definitions » Peter Lynch Fair Value
中文

Waters (Waters) Peter Lynch Fair Value : $124.54 (As of Apr. 24, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Waters Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Waters's PEG is 1. Waters's 5-Year TTM EBITDA Growth Rate is 11.51. Waters's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $10.82. Therefore, the Peter Lynch Fair Value for today is $124.54.

As of today (2024-04-24), Waters's share price is $310.25. Waters's Peter Lynch fair value is $124.54. Therefore, Waters's Price to Peter Lynch Fair Value Ratio for today is 2.49.


The historical rank and industry rank for Waters's Peter Lynch Fair Value or its related term are showing as below:

WAT' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 2.19   Med: 2.78   Max: 3.59
Current: 2.49


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Waters was 3.59. The lowest was 2.19. And the median was 2.78.


WAT's Price-to-Peter-Lynch-Fair-Value is ranked worse than
80% of 50 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.655 vs WAT: 2.49

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Waters Peter Lynch Fair Value Historical Data

The historical data trend for Waters's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters Peter Lynch Fair Value Chart

Waters Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.93 78.20 124.52 141.59 124.54

Waters Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.59 136.17 133.71 129.06 124.54

Competitive Comparison of Waters's Peter Lynch Fair Value

For the Diagnostics & Research subindustry, Waters's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waters's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Waters's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Waters's Price-to-Peter-Lynch-Fair-Value falls into.



Waters Peter Lynch Fair Value Calculation

Waters's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 11.51 *10.82
=124.54

Waters's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.82.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Waters  (NYSE:WAT) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 11.51 instead of 15 in this case.

Waters's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=310.25/124.54
=2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waters Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Waters's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Waters (Waters) Business Description

Traded in Other Exchanges
Address
34 Maple Street, Milford, MA, USA, 01757
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.
Executives
Christopher A Kuebler director 210 CARNEGIE CENTER, PRINCETON NJ 08540
Richard H Fearon director 1239 GERBING ROAD, AMELIA ISLAND FL 32034
Edward Conard director
Daniel J. Brennan director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Mark P Vergnano director 1007 MARKET STREET, WILMINGTON DE 19898
Gary E Hendrickson director 1101 THIRD STREET SOUTH, MINNEAPOLIS MN 55415
John M Ballbach director
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Michael J Berendt director
Thomas P Salice director
Wei Jiang director 34 MAPLE STREET, MILFORD MA 01757
Amol Chaubal officer: SVP and Chief Financial Office 113 HARTWELL AVE, C/O QUANTERIX CORPORATION, LEXINGTON MA 02421
Jianqing Bennett officer: SVP TA Instruments Division 34 MAPLE STREET, MILFORD MA 01757
Joann A Reed director C/O AMERICAN TOWER CORP, 116 HUNTINGTON AVENUE, BOSTON MA 02116
Belinda Hyde officer: SVP, Global Human Resources 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277

Waters (Waters) Headlines

From GuruFocus

Waters Corp at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Waters Corp Investor Day Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024